M Louise Markert Selected Research

DiGeorge Syndrome (Syndrome, DiGeorge)

1/2022	Introducing thymus for promoting transplantation tolerance.
12/2017	Thymus transplantation for complete DiGeorge syndrome: European experience.
9/2014	Clinical course and outcome predictors of critically ill infants with complete DiGeorge anomaly following thymus transplantation.
10/2012	Diagnosis of 22q11.2 deletion syndrome and artemis deficiency in two children with T-B-NK+ immunodeficiency.
12/2011	Interpreting low T-cell receptor excision circles in newborns with DiGeorge anomaly: importance of assessing naive T-cell markers.
6/2011	Induction of tolerance to parental parathyroid grafts using allogeneic thymus tissue in patients with DiGeorge anomaly.
6/2011	Successful extracorporeal membrane oxygenation for respiratory failure in an infant with DiGeorge anomaly, following thymus transplantation.
5/2010	Thymus transplantation.
6/2009	The dynamics of T-cell receptor repertoire diversity following thymus transplantation for DiGeorge anomaly.
1/2009	Characterization of cultured thymus tissue used for transplantation with emphasis on promiscuous expression of thyroid tissue-specific genes.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

M Louise Markert Research Topics

Disease

18	DiGeorge Syndrome (Syndrome, DiGeorge) 01/2022 - 08/2003
3	Lymphadenopathy 10/2004 - 08/2003
3	Exanthema (Rash) 10/2004 - 08/2003
2	Infections 01/2022 - 07/2015
2	Sepsis (Septicemia) 09/2014 - 06/2011
2	Thyroid Diseases (Thyroid Disease) 01/2011 - 01/2009
2	Hypothyroidism 05/2007 - 08/2003
1	Inborn Genetic Diseases (Disease, Hereditary) 01/2022
1	Hemolysis 12/2017
1	Septic Shock (Toxic Shock Syndrome) 12/2017
1	Pneumothorax 12/2014
1	Congenital Heart Defects (Congenital Heart Defect) 09/2014
1	Critical Illness (Critically Ill) 09/2014
1	Disease Progression 09/2014
1	Hypoparathyroidism 06/2011
1	Respiratory Insufficiency (Respiratory Failure) 06/2011
1	Disease Susceptibility (Diathesis) 09/2009
1	Netherton Syndrome 09/2009
1	Ichthyosis (Xeroderma) 09/2009
1	Primary Immunodeficiency Diseases 09/2009
1	Enteritis 05/2007
1	Asthma (Bronchial Asthma) 01/2004
1	X-Linked Combined Immunodeficiency Diseases (X Linked Severe Combined Immunodeficiency) 01/2004
1	Pneumonia (Pneumonitis) 08/2003
1	Thrombocytopenia (Thrombopenia) 08/2003
1	Eosinophilia 08/2003
1	Cytomegalovirus Infections (Inclusion Disease) 08/2003
1	Alopecia (Baldness) 08/2003

Drug/Important Bio-Agent (IBA)

3	T-Cell Antigen Receptors (T-Cell Receptor)IBA 12/2011 - 04/2004
2	MitogensIBA 10/2004 - 04/2004
1	Clarithromycin (Biaxin)FDA LinkGeneric 07/2015
1	Azithromycin (Zithromax)FDA LinkGeneric 07/2015
1	Serine Peptidase Inhibitor Kazal-Type 5IBA 09/2009
1	Serine Proteinase Inhibitors (Serine Protease Inhibitors)IBA 09/2009
1	Intravenous Immunoglobulins (IVIG)FDA Link 09/2009
1	thymoglobulin FDA Link 10/2004
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2004
1	PhytohemagglutininsIBA 08/2003
1	Immunoglobulin E (IgE)IBA 08/2003

Therapy/Procedure

16	Transplantation 12/2017 - 08/2003
4	Therapeutics 01/2022 - 10/2004
2	Aftercare (After-Treatment) 12/2017 - 10/2004
1	Organ Transplantation 01/2022
1	Positive-Pressure Respiration (Positive End-Expiratory Pressure) 12/2014
1	Hematopoietic Stem Cell Transplantation 10/2012
1	Extracorporeal Membrane Oxygenation 06/2011
1	Tracheostomy 08/2003
1	Artificial Respiration (Mechanical Ventilation) 08/2003